In a study of 225 different types of human tumors, increased Glo1 copy number was discovered in 8% of tumors, with the highest prevalence of Glo1 amplification in breast cancer (22%), followed by sarcomas (17%) and non-small cell lung cancer (11%) (73). Here, GLO1 is linked to sarcoma.